Literature DB >> 32128909

Cancer worry and empathy moderate the effect of a survivorship-focused intervention on quality of life.

Patricia A Parker1,2, Smita C Banerjee1,2, Matthew J Matasar3,4, Carma L Bylund1,5, Elizabeth Schofield1, Yuelin Li1,2, Paul B Jacobsen6, Alan B Astrow7, Howard Leventhal8, Steven Horwitz3,4, David Kissane1,2,9.   

Abstract

OBJECTIVE: This study examined the impact of a survivorship planning consultation (SPC) for patients with Hodgkin's lymphoma and diffuses large B-cell lymphoma on quality of life (QOL). We specifically assessed two potential moderators, cancer worry and perceived empathy, of the intervention effects on QOL.
METHODS: This cluster randomized, four-site trial examined the efficacy of a SPC; physicians received communication skills training and applied these skills in a survivorship-focused office visit using a care plan vs a control arm in which physicians were trained to and subsequently provided a time-controlled, manualized wellness rehabilitation consultation focused only on discussion of healthy nutrition and exercise. We examined the effect of the intervention on patients' QOL and examined potential moderators-cancer worry and perceived physician empathy.
RESULTS: Forty-two physicians and 198 patients participated. There was no main effect of the intervention on any of the QOL dimensions (ps > 0.10). However, cancer worry was a significant moderator of the effects of the intervention on three QOL domains (physical P = .04; social P = .04; spiritual P = .01) and perceived empathy was a significant moderator of QOL (physical P = .004; psychological P = .04; social P = .01). Specifically, the beneficial effects of the intervention were more pronounced among patients who initially reported higher levels of cancer worry and lower levels of physician empathy.
CONCLUSIONS: This study identified two factors, perceived empathy and cancer worry, that were found to impact the QOL of patients who participated in this communication-based survivorship intervention.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  communication; empathy; lymphoma; moderators; quality of life; survivorship; worry

Mesh:

Year:  2020        PMID: 32128909      PMCID: PMC8327217          DOI: 10.1002/pon.5371

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  31 in total

1.  In which context is physician empathy associated with cancer patient quality of life?

Authors:  Sophie Lelorain; Stéphane Cattan; Florian Lordick; Anja Mehnert; Christophe Mariette; Véronique Christophe; Alexis Cortot
Journal:  Patient Educ Couns       Date:  2018-02-01

2.  How and for whom? Mediation and moderation in health psychology.

Authors:  David P MacKinnon; Linda J Luecken
Journal:  Health Psychol       Date:  2008-03       Impact factor: 4.267

3.  Screening for psychological distress in cancer patients: challenges and opportunities.

Authors:  Paul B Jacobsen
Journal:  J Clin Oncol       Date:  2007-09-10       Impact factor: 44.544

4.  Addressing fear of cancer recurrence among women with cancer: a feasibility and preliminary outcome study.

Authors:  Sophie Lebel; Christine Maheu; Monique Lefebvre; Scott Secord; Christine Courbasson; Mina Singh; Lynne Jolicoeur; Aronela Benea; Cheryl Harris; Michael Fung Kee Fung; Zeev Rosberger; Pamela Catton
Journal:  J Cancer Surviv       Date:  2014-04-23       Impact factor: 4.442

5.  Effectiveness of treatment summaries in increasing breast and colorectal cancer survivors' knowledge about their diagnosis and treatment.

Authors:  Mary Jo Nissen; Michaela L Tsai; Anne H Blaes; Karen K Swenson; Susan Koering
Journal:  J Cancer Surviv       Date:  2013-02-17       Impact factor: 4.442

6.  Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer.

Authors:  Eva Grunfeld; Jim A Julian; Gregory Pond; Elizabeth Maunsell; Douglas Coyle; Amy Folkes; Anil A Joy; Louise Provencher; Daniel Rayson; Dorianne E Rheaume; Geoffrey A Porter; Lawrence F Paszat; Kathleen I Pritchard; André Robidoux; Sally Smith; Jonathan Sussman; Susan Dent; Jeffrey Sisler; Jennifer Wiernikowski; Mark N Levine
Journal:  J Clin Oncol       Date:  2011-10-31       Impact factor: 44.544

Review 7.  A systematic review of the associations between empathy measures and patient outcomes in cancer care.

Authors:  Sophie Lelorain; Anne Brédart; Sylvie Dolbeault; Serge Sultan
Journal:  Psychooncology       Date:  2012-01-11       Impact factor: 3.894

8.  Randomized Controlled Trial of Survivorship Care Plans Among Low-Income, Predominantly Latina Breast Cancer Survivors.

Authors:  Rose C Maly; Li-Jung Liang; Yihang Liu; Jennifer J Griggs; Patricia A Ganz
Journal:  J Clin Oncol       Date:  2017-04-18       Impact factor: 44.544

9.  Determinants and patient-reported long-term outcomes of physician empathy in oncology: a structural equation modelling approach.

Authors:  Melanie Neumann; Markus Wirtz; Elfriede Bollschweiler; Stewart W Mercer; Mathias Warm; Jürgen Wolf; Holger Pfaff
Journal:  Patient Educ Couns       Date:  2007-09-11

10.  Fear of cancer recurrence in colorectal cancer survivors.

Authors:  José A E Custers; Marieke F M Gielissen; Stephanie H V Janssen; Johannes H W de Wilt; Judith B Prins
Journal:  Support Care Cancer       Date:  2015-06-25       Impact factor: 3.603

View more
  3 in total

1.  Thinking ahead: Parents' worries about late effects of childhood cancer treatment.

Authors:  Katie A Greenzang; Colleen A Kelly; Hasan Al-Sayegh; Clement Ma; Jennifer W Mack
Journal:  Pediatr Blood Cancer       Date:  2021-09-14       Impact factor: 3.167

2.  Empathic communication: The premise of inclusive care for historically excluded populations.

Authors:  William E Rosa; Smita C Banerjee; Amanda L Kastrinos; Patricia A Parker
Journal:  Cancer       Date:  2022-04-26       Impact factor: 6.921

3.  Effect of the COVID-19 pandemic on surgical oncology practice-Results of an SSO survey.

Authors:  Yelizaveta Gribkova; Catherine H Davis; Alissa A Greenbaum; Shou-En Lu; Adam C Berger
Journal:  J Surg Oncol       Date:  2022-03-06       Impact factor: 2.885

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.